IFN alfacon-1 may be valuable in the treatment of SARS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1419, 2004-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IFN- -1b: potent antiviral activity against SARS coronavirus

Inpharma, Vol. 1, Iss. 1398, 2003-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Interferon Alfacon-1: A Review of its Pharmacology and Therapeutic Efficacy in the Treatment of Chronic Hepatitis C

By Melian E.B. Plosker G.L.

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1661-1691

Adis International

Access to resources Recommend Favorite

Interferon-alfacon-1 shows efficacy in patients with chronic hepatitis C who have not responded to, or relapsed after, prior therapy with IFN- -2b plus ribavirin

Inpharma, Vol. 1, Iss. 1256, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Identification and treatment of SARS

Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Interferon alfacon-1: First report of immune thrombocytopenic purpura: case report

Reactions Weekly, Vol. 1, Iss. 1038, 2005-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite